Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Abroad (travel likely)Recruiting

Conditions

Peritoneal Dialysis Complication · Renal Function Aggravated · Sodium-glucose Co-transporter-2 Inhibitors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospita, Chengdu, Sichuan, China
Contact: Study coordinator (Jin Chen, MD) · jessicakxcj@uestc.edu.cn · 0086-28-87393195
Contact: Study coordinator (Xin Yi Tan, Master) · 0086-28-87393195

Study leads

Jin Chen, MD
Principal Investigator
Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Peritoneal Dialysis Complication · End Stage Kidney Disease · Sodium-glucose Co-transporter-2 Inhibitors

Abroad (travel likely)RecruitingPHASE3

Toronto, Canada

Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.

End Stage Chronic Renal Failure

Abroad (travel likely)Recruiting

Nizwa, Oman

International (Pediatric) Peritoneal Biobank

Kidney Failure, Chronic · Peritoneal Dialysis Complication · Transplantation

Abroad (travel likely)Recruiting

Birmingham, United States · Kansas City, United States

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

Hypertension · Peritoneal Dialysis · End Stage Kidney Disease (ESRD)

Abroad (travel likely)RecruitingPHASE4

Hong Kong, Hong Kong